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Abstract
Adjusting for prognostic baseline variables can lead to improved power in randomized trials. For bi-
nary outcomes, a logistic regression estimator is commonly used for such adjustment. This has resulted
in substantial efficiency gains in practice, e.g., gains equivalent to reducing the required sample size by
20–28% were observed in a recent survey of traumatic brain injury trials. Robinson and Jewell (1991)
proved that the logistic regression estimator is guaranteed to have equal or better asymptotic efficiency
compared to the unadjusted estimator (which ignores baseline variables). Unfortunately, the logistic
regression estimator has the following dangerous vulnerabilities: it is only interpretable when the treat-
ment effect is identical within every stratum of baseline covariates; also, it is inconsistent under model
misspecification, which is virtually guaranteed when the baseline covariates are continuous or categori-
cal with many levels. An open problem was whether there exists an equally powerful, covariate-adjusted
estimator with no such vulnerabilities, i.e., one that (i) is interpretable and consistent without requiring
any model assumptions, and (ii) matches the efficiency gains of the logistic regression estimator. Such
an estimator would provide the best of both worlds: interpretability and consistency under no model
assumptions (like the unadjusted estimator) and power gains from covariate adjustment (that match the
logistic regression estimator). We prove a new asymptotic result showing that, surprisingly, there are
simple estimators satisfying the above properties. We argue that these rarely used estimators have sub-
stantial advantages over the more commonly used logistic regression estimator for covariate adjustment
in randomized trials with binary outcomes. Though our focus is binary outcomes and logistic regression
models, our results extend to a large class of generalized linear models.
Keywords: Pitman Efficiency; Robustness; Hypothesis Test
1 Introduction
Austin et al. (2010) conducted a review of randomized clinical trial reports from medical journals, and
concluded that “There is a need for an informed debate about the relative interpretability and utility for
1
Hosted by The Berkeley Electronic Press
clinical and policy decision making of unadjusted vs. adjusted measures of treatment effect for binary and
time-to-event outcomes.” We aim to contribute to this debate, focusing on binary outcomes. Our goal is
to recommend an estimator (with corresponding confidence interval and hypothesis test) for the primary
efficacy analysis of a confirmatory randomized trial.
Adjusting for prognostic baseline variables can lead to efficiency gains, as illustrated by Herna´ndez et al.
(2006). They estimated the gains from adjusting for baseline covariates in seven phase 3 randomized trials
of treatments for traumatic brain injury. The primary outcome in each trial was the dichotomized Glasgow
Outcome Scale of functional disability measured at 6 months. Prognostic baseline variables included “age,
motor score, pupillary reactivity, computed tomography (CT) classification, traumatic subarachnoid hem-
orrhage, hypoxia, hypotension, glycemia, and hemoglobin” (Herna´ndez et al., 2006). A logistic regression
estimator was compared to the unadjusted estimator. The former, referred to below as the logistic coefficient
estimator, is the estimated coefficient on the treatment term in a main effects logistic regresssion model for
the outcome given treatment and baseline variables. The unadjusted estimator is the difference between
the sample proportions of successful outcomes in the two study arms. Efficiency gains from using the lo-
gistic coefficient estimator compared to the unadjusted estimator were equivalent to sample size reductions
ranging from 20–28%.
We consider trials where each participant is randomized to the treatment or control arm, independent
of baseline variables; extensions to stratified randomization are discussed in Section 6. Our focus is the
intention-to-treat analysis, which compares the impact of assignment to the treatment versus control arm.
The goal of the analysis is to estimate the average treatment effect, construct a confidence interval for it,
and test the null hypothesis of no average treatment effect. We compare three estimators: the unadjusted,
the logistic coefficient, and the standardized estimator. The latter two are adjusted estimators that leverage
information in baseline variables, and are defined in Section 2.3. Each estimator can be used for hypothesis
testing by dividing by its standard error and comparing to the appropriate quantile of the standard normal
distribution.
Asymptotic relative efficiency (also called Pitman efficiency) is used to compare test statistics from
different estimators. It represents the ratio of sample sizes required to achieve a desired power and Type I
error, comparing two testing methods. We refer to asymptotic relative efficiency simply as “efficiency” for
conciseness.
Robinson and Jewell (1991, Section 8) compared the efficiency of the logistic coefficient estimator
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versus the unadjusted estimator. They proved that the former has equal or better efficiency compared to the
latter, assuming the logistic regression model is correctly specified.
It was an open problem to determine whether the logistic coefficient estimator or the standardized es-
timator is more efficient for testing the null hypothesis of no average treatment effect. This was unknown
both for the case where the logistic regression model is correctly specified, and also for the case where the
model is misspecified. The latter case may be most important, since in practice one would expect the model
to be at least somewhat misspecified.
Our main contribution is proving that the standardized estimator has equal efficiency compared to the
logistic coefficient estimator; this holds not only when the logistic regression model is correctly specified,
but also under arbitrary model misspecification. Therefore, there is no advantage in terms of power gains,
asymptotically, to using the logistic coefficient estimator compared to the standardized estimator. This is
important since the latter estimator has substantial advantages compared to the former.
The main advantage of the standardized estimator is its interpretability. The population parameter es-
timated by the standardized estimator is the same as that estimated by the unadjusted estimator, i.e., the
average treatment effect. This effect, also called a marginal or unconditional effect, has the direct interpreta-
tion as a contrast between the probability of a successful outcome if everyone in the target population were
assigned to treatment versus control. If the average effect is positive, then giving the treatment to everyone
in the target population would lead to better outcomes, on average, compared to control. The standard-
ized estimator is guaranteed to converge to the average treatment effect, regardless of whether the logistic
regression model is correctly specified or not.
The population parameter estimated by the logistic coefficient estimator is the conditional treatment ef-
fect within strata of the baseline variables. This estimator is only interpretable under the assumption that the
conditional effect is identical within every such stratum, i.e., under the assumption that the conditional effect
is a single number rather than a function that can vary depending on baseline variables (Freedman, 2008).
Even if this assumption were true, the logistic coefficient estimator is inconsistent under misspecification of
the logistic regression model.
In brief, our main result shows that the standardized estimator gets all the asymptotic efficiency gains
of the logistic coefficient estimator without the interpretability and inconsistency problems of the latter. We
focus on the standardized estimator of Moore and van der Laan (2009) due to its simplicity and ease of
implementation. Our result also has implications for a variety of standardized estimators, e.g., those based
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on (Robins et al., 2007; Moore and van der Laan, 2009; Tan, 2010; Rotnitzky et al., 2012; Gruber and van der
Laan, 2012; Colantuoni and Rosenblum, 2015) when applied to randomized trials, as discussed in Section 6.
2 Problem Definition
2.1 Data Structure and Assumptions
Let Y denote the binary outcome, A denote assignment to treatment (A = 1) or control (A = 0), and B
denote a column vector of baseline variables which can be any mix of categorical and continuous variables
measured before randomization. The baseline variables B must be prespecified in the study protocol. Each
participant i has data vector (Bi, Ai, Yi). A total of n participants are enrolled.
Each participant’s data vector (Bi, Ai, Yi) is assumed to be an independent, identically distributed draw
from the unknown joint distribution P0 on (B,A, Y ). No assumptions are made on P0 except that A is a
Bernoulli draw with probability 1/2 of being 0 or 1 independent of B (which holds by randomization), B is
bounded, and P0 satisfies regularity conditions given later in the paper.
2.2 Treatment Effect and Null Hypothesis Definitions
Define the unconditional probability of success under treatment and control to be
µ1 = P0(Y = 1|A = 1) and µ0 = P0(Y = 1|A = 0), respectively. These probabilities are nonparametri-
cally defined, i.e., they do not require any model assumptions (such as a logistic regression model) in order
to be well-defined and interpretable. We focus throughout on testing the null hypothesis of no average treat-
ment effect: H0 : µ1 = µ0. The average treatment effect on the risk difference scale is defined as µ1 − µ0.
The analogous average treatment effects on the relative risk and log-odds scales are defined as µ1/µ0 and
logit(µ1)− logit(µ0), respectively, for logit(x) = log{x/(1− x)}.
Define the following logistic regression model for the outcome given study arm assignment and baseline
variables:
logit{P (Y = 1|A,B)} = γ0 + γ1A+ γ′2B, (1)
where γ2 is a column vector of same length asB, and γ′2 denotes its transpose. We do not assume this model
is correctly specified. That is, the true joint distribution P0(B,A, Y ) need not satisfy any of the restrictions
encoded in this model (such as equal conditional treatment effect within every stratum of baseline variables,
and the relationship between the outcome and baseline variables having the simple, linear form above for
each study arm). Our only assumptions about P0 are those in Section 2.1.
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If the model (1) is correct, then H0 is equivalent to the conditional null hypothesis
H0C : P (Y = 1|A = 1, B = b) = P (Y = 1|A = 0, B = b) for every stratum b of baseline variables
with positive density under P ; this follows since if the model is correct, each null hypothesis is equivalent to
γ1 = 0. If the model is misspecified, then H0 does not necessarily imply the sharper null hypothesis H0C .
In general, neither null hypothesis implies the model (1) is correctly specified. (An exception is when B is
a single binary variable, in which case H0C implies the model is correctly specified.) We focus on testing
H0 rather than H0C , since the former is typically of primary interest in confirmatory randomized trials.
2.3 Estimators
The unadjusted estimator ψˆunadj of the marginal risk difference µ1−µ0 is the difference between the sample
proportions with Y = 1 between the treatment and control arms.
Let γˆ = (γˆ0, γˆ1, γˆ2) denote the estimated coefficients when (1) is fit using maximum likelihood esti-
mation. The logistic coefficient estimator is defined as γˆ1. Even when the model (1) is misspecified, γˆ
converges in probability to the maximizer γ¯ of the expected log-likelihood
EP0 log
{
expit
(
γ0 + γ1A+ γ
′
2B
)}Y {
1− expit (γ0 + γ1A+ γ′2B)}1−Y ,
where expit = logit−1, EP0denotes expectation with respect to P0, and we assume throughout that the
expected log-likelihood has a unique maximizer. (Rosenblum and van der Laan (2009) showed that if the
components of B are linearly independent, then the expected log-likelihood is strictly concave and so any
local maximum is the unique, global maximum.) Under misspecification of (1), the probability limit γ¯1 of
the logistic coefficeint estimator γˆ1 is generally uninterpretable.
The standardized estimator of the marginal risk difference is defined as:
ψˆstd =
1
n
n∑
i=1
expit(γˆ0 + γˆ1 + γˆ
′
2Bi)−
1
n
n∑
i=1
expit(γˆ0 + γˆ
′
2Bi). (2)
This estimator is from Moore and van der Laan (2009), and is a special case of a class of estimators from
Scharfstein et al. (1999). We emphasize that each of the sums in (2) is over all participants i = 1, . . . , n
in the trial (not only those assigned to a specific arm, for example). The estimator can be thought of as
standardizing to the marginal distribution of the baseline variables from the entire (pooled) data set.
The Wald statistic corresponding to each estimator is the estimator divided by its standard error. Through-
out, we assume that a robust variance estimator (such as the nonparametric bootstrap) is used to compute
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each standard error, and that this robust variance estimator is consistent.
2.4 Validity of Hypothesis Tests Based on Each Estimator
It follows from Scharfstein et al. (1999) and Moore and van der Laan (2009) that under arbitrary misspecifi-
cation of the model (1), both ψˆunadj and ψˆstd converge in probability to µ1−µ0 (the average treatment effect
on the risk difference scale) and are asymptotically normal. Therefore, under H0, these estimators converge
to 0 in probability and their corresponding Wald statistics lead to tests ofH0 that have asymptotically correct
Type I error; this holds regardless of whether the model (1) is correctly specified.
In contrast, the logistic coefficient estimator γˆ1 converges to the conditional effect
logit{P (Y = 1|A = 1, B)} − logit{P (Y = 1|A = 0, B)} (also called the conditional log-odds ratio)
when (1) is correctly specified, and converges to an uninterpretable limit γ¯ otherwise (Freedman, 2008).
Gail et al. (1984) showed that when (1) is correctly specified and H0 is false, the conditional effect has
greater magnitude than the marginal effect on the log-odds scale. The logistic coefficient estimator γˆ1 is
asymptotically normal, regardless of whether (1) holds.
Rosenblum and van der Laan (2009) proved that for testing H0C , the Wald test based on the logistic
coefficient estimator γˆ1 has asymptotically correct Type I error; this holds under arbitrary misspecification
of the model (1). We strengthen this result, showing that the Wald test based on γˆ1 is also valid for testing the
weaker null hypothesis H0. This result and several results above are encapsulated in the following theorem:
Theorem 2.1. For each estimator ψˆunadj , γˆ1, ψˆstd, it converges to 0 in probability if and only if H0 is true.
Therefore, the Wald test of H0 based on any of these estimators has asymptotically correct Type I error.
These results hold under arbitrary misspecification of the model (1).
All of our results are proved in the Appendix. We next compare the power of Wald tests based on the
above estimators.
3 Main Result
Asymptotic relative efficiency, defined by Pitman (van der Vaart, 1998, p. 201), compares the large sample
performance of two testing procedures. It represents the ratio of required sample sizes for each testing
procedure to achieve a desired power and Type I error. The formal definition requires a set of alternatives
P (ν)(B,A, Y ) (i.e., joint distributions) indexed by {ν ∈ R : ν > 0} that converge to some P (0) ∈ H0 as
ν ↓ 0. The asymptotic relative efficiency for testing H0 is the limit of the ratio of the minimum sample sizes
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needed by each testing procedure to achieve a desired power 1− β with Type I error at most α, under P (ν)
as ν ↓ 0. Our results hold for many possible sets of alternatives {P (ν) : ν > 0}, and for any α, β satisfying
0 < α < 1− β < 1, under regularity conditions in the next paragraph.
We assume that P (ν) converges in total variation distance to some P (0) ∈ H0 as ν ↓ 0, and that each P (ν)
satisfies the assumptions in Section 2.1. Define µa(ν) = P (ν)(Y = 1|A = a) for each a ∈ {0, 1}, ν ≥ 0.
For any ν > 0, P (ν) is assumed to satisfy the alternative hypothesis µ1(ν) − µ0(ν) > 0. (We focus
on one-sided alternatives, but analogous results hold for the two-sided case.) Furthermore, we assume
µ1(ν) − µ0(ν) is right differentiable at ν = 0, with positive right-derivative. Intuitively, this condition
means that the parameter µ1(ν) − µ0(ν), which defines the null hypothesis H0 : µ1(ν) − µ0(ν) = 0, is
increasing in ν (to first order) in small neighborhoods of ν = 0. We assume the regularity conditions in
Lemma 7.6 and Theorem 14.19 of van der Vaart (1998, pp. 95, 201). The former conditions imply that
the parametrization {P (ν) : ν ≥ 0} is regular, i.e., differentiable in quadratic mean. The latter conditions
imply that asymptotic relative efficiency is determined by the slope of each Wald statistic, i.e., the ratio of
the derivative of its asymptotic mean to its asymptotic dispersion.
An example of a set of alternatives satisfying the above assumptions is to let P (ν) denote the distribution
satisfying (1) at γ1 = ν and with γ0, γ2, and the marginal distribution of B fixed (not changing with ν).
The following is our main result:
Theorem 3.1. Consider any set of alternatives {P (ν) : ν > 0} satisfying the above regularity conditions.
The asymptotic relative efficiency for testing H0, comparing Wald statistics based on the standardized esti-
mator versus the logistic coefficient estimator, is 1.
The theorem shows that the standardized estimator is asymptotically as efficient as the logistic coefficient
estimator. This holds regardless of whether the logistic regression model (1) is correctly specified; that is,
we do not require P (ν) or P (0) to satisfy (1).
Robinson and Jewell (1991) showed that the asymptotic relative efficiency of the logistic coefficient
estimator compared to the unadjusted estimator is greater or equal to 1, assuming the model (1) is correct.
In the Appendix, we slightly extend their result by showing it holds in the setting of our paper. Combining
this with Theorem 3.1, we have:
Corollary 3.2. Consider any P (0) ∈ H0 for which (1) is correctly specified, and any set of alternatives
{P (ν) : ν > 0} that satisfy the above regularity conditions and converge to P (0) in total variation dis-
tance as ν ↓ 0. The asymptotic relative efficiency for testing H0, comparing Wald statistics based on the
standardized estimator versus the unadjusted estimator, is at least 1.
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(Asymptotic relative efficiency greater than 1 means that the first procedure requires smaller sample size
compared to the second procedure, asymptotically.)
Theorems 2.1–3.1 and Corollary 1 involve the standardized estimator for the risk difference µ1 − µ0.
These results still hold if the risk difference in the standardized estimator is replaced by any smooth contrast
between µ1 and µ0, such as the relative risk reduction 1 − µ1/µ0 or log-odds ratio logit(µ1) − logit(µ0).
In general, we define a smooth contrast between the marginal means µ0, µ1 to be any real-valued function
r of (µ0, µ1) that is continuously differentiable, equals 0 under H0 (i.e., whenever µ0 = µ1), and has
gradient with non-zero magnitude. The corresponding standardized estimator involves substituting the first
and second terms on the right side of (2) for µ1 and µ0, respectively, in the contrast r.
Theorem 3.3. The standardized estimator using any smooth contrast r converges to 0 in probability if and
only if H0 is true. The asymptotic relative efficiency for testing H0, comparing Wald statistics based on the
standardized estimator using the risk difference versus the standardized estimator using any smooth contrast
r, is 1.
4 Simulation Study Based on the MISTIE II trial
The MISTIE II trial (Hanley et al., In Press) is a randomized phase II trial comparing a surgical procedure
that removes blood clots to the standard of care in patients who have intracerebral hemorrhage. The primary
outcome has value 1 if the participant’s modified Rankin scale score at 180 days is 3 or less, and is 0
otherwise. We use the following prognostic baseline variables: age, intracerebral hemorrhage volume, and
National Institutes of Health Stroke Scale. We use data from the 89 participants (out of 96 total) in the
trial who have all of these variables and the outcome measured. The unadjusted estimate of the average
treatment effect on the risk difference scale is 0.12; it is 0.54 on the log-odds scale. Our simulation study
setup is similar to (Colantuoni and Rosenblum, 2015); however, they did not consider the logistic coefficient
estimator, whose relative efficiency compared to the standardized estimator is the focus of our paper.
We compare the efficiency of the unadjusted, logistic coefficient, and standardized estimators by simu-
lating 10000 trials, each with sample size 89. The data generating mechanism is constructed to mimic the
correlation structure between the outcome and baseline variables in the MISTIE II data. Each simulated trial
data set involves first sampling 89 pairs (Y,B) with replacement from the MISTIE II data. Each simulated
participant’s treatment assignment A is set to be treatment or control with probability 0.5 independent of
(Y,B). In order to induce a positive average treatment effect equal to that observed in the MISTIE II trial,
we modify some of the simulated participants’ outcomes. Specifically, for each simulated participant with
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A = 1 and Y = 0, we change Y to 1 with probability 0.17 based on a random draw independent of B.
The resulting data generating distribution has average treatment effect 0.12 on the risk difference scale, and
average treatment effect 0.54 on the log-odds scale. Under this distribution, the logistic regression model
(1) is misspecified.
The relative efficiency comparing Wald statistics based on two estimators is approximated below by the
ratio of the first estimator’s signal to noise ratio (defined as the square of its mean divided by its variance)
compared to that of the second estimator. Each mean and variance is approximated by its empirical mean
and variance over the 10000 simulated trials.
Table 1 shows results from the 10000 simulated trials. The unadjusted and standardized estimators are
calculated both on the risk difference and log-odds scales. For each estimator, the table shows its empirical
mean and standard error. Relative efficiency compares the Wald test of H0 based on each estimator to the
Wald test of H0 based on the logistic coefficient estimator.
Risk Difference Scale Log Odds Scale
Unadjusted Standardized Unadjusted Standardized Logistic
Mean 0.12 0.12 0.54 0.54 0.70
Standard Error 0.10 0.09 0.46 0.41 0.54
Relative Efficiency 0.86 1.04 0.83 1.02 1.00
Table 1: Comparison of the unadjusted, standardized, and logistic coefficient estimators.
The results in Table 1 show that both the unadjusted and standardized estimator are approximately
unbiased for the average treatment effect. The relative efficiency results in Table 1 agree well with the results
from Theorem 3.1 and Corollary 1. The unadjusted estimator is less efficient than both the standardized and
the logistic coefficient estimators. The relative efficiency of the standardized versus the logistic coefficient
estimator is close to 1. We also conducted simulations as above except with sample size 500; the relative
efficiency of the standardized versus the logistic coefficient estimator becomes closer to one, with relative
efficiencies of 1.01 and 0.99 when the standardized estimator is on the risk difference and log-odds scale,
respectively. Consistent with Theorem 3.3, the relative efficiencies of the standardized estimator in Table 1
are similar for both the risk difference and log-odds scales.
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5 Generalized Linear Models with Canonical Link Functions
Our results hold not only for binary outcomes and logistic regression models, but also for generalized linear
models (GLM) with canonical link function (denoted g), under regularity conditions given below. This
includes the following special cases from McCullagh and Nelder (1989):
• Linear regression for continuous outcomes (g(x) = x).
• Logistic regression for binary outcomes (g(x) = logit(x)).
• Poisson regression for count outcomes (g(x) = log(x)).
• Gamma regression for positive, real-valued outcomes (g(x) = 1/x).
• Inverse-normal regression for positive, real-valued outcomes (g(x) = 1/x2).
We consider the same data structure and assumptions as in Section 2.1 with the exception that the
outcome Y is not restricted to be binary. We generalize the definitions of µ0, µ1 from Section 2.2 to be
µ0 = E(Y |A = 0), µ1 = E(Y |A = 1), respectively. We focus on testing the null hypothesisH0 : µ1 = µ0.
The terms in the linear part of the GLM are assumed to be the same as in (1). Under such a generalized
linear model with link function g, we have the following extension of (1):
g {E(Y |A,B)} = γ0 + γ1A+ γ′2B. (3)
If we further assume the link function is canonical, then it follows from Bickel and Doksum (2015, p.
413) that the corresponding maximum likelihood estimator (γˆ0, γˆ1, γˆ2) for (γ0, γ1, γ2) is the solution to the
following estimating equations:
n∑
i=1
{
Yi − g−1(γ0 + γ1Ai + γ′2Bi)
}
(1, Ai, B
′
i)
′ = 0. (4)
In this section, we define γˆ = (γˆ0, γˆ1, γˆ2) to be the solution (γ0, γ1, γ2) to the above display. Define the
GLM coefficient estimator to be γˆ1.
We consider the same setup and assumptions as in Section 3. Our results apply to a large class of
smooth functions g, which include the five special cases given above. We make the following assumptions
on g: g is continuously differentiable; g is invertible with strictly monotone inverse; for all γ we have
E{h˙(γ0 + γ1A+ γ′2B)} is finite, where h = g−1 and h˙ is the derivative of h. We also assume the regularity
10
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conditions of Theorems 5.9 and 5.21 of van der Vaart (1998, pp. 46, 52), which imply that γˆ converges in
probability to the unique solution toE
{
Y − g−1(γ0 + γ1A+ γ′2B)
}
(1, A,B′)′ = 0, and is asymptotically
normal. We do not assume that the model (3) is correctly specified.
For a given function g, the corresponding standardized estimator ψˆstd is defined as (2) with expit re-
placed by g−1, i.e.,
ψˆstd =
1
n
n∑
i=1
g−1(γˆ0 + γˆ1 + γˆ′2Bi)−
1
n
n∑
i=1
g−1(γˆ0 + γˆ′2Bi). (5)
Rosenblum and van der Laan (2010) showed that the standardized estimator is a consistent estimator for the
average treatment effect E(Y |A = 1)−E(Y |A = 0) even if the model (3) is arbitrarily misspecified. They
showed this for each of the five special cases of generalized linear models with canonical link functions g
given above. We generalize their result by proving that it holds for the large class of functions g defined
above. This result and a generalization of Theorem 2.1 are encapsulated in the following theorem:
Theorem 5.1. Consider any function g satisfying the assumptions above. Then the standardized estimator
ψˆstd defined in (5) converges in probability to E(Y |A = 1)−E(Y |A = 0). For each estimator ψˆunadj , γˆ1,
ψˆstd, it converges to 0 in probability if and only if H0 is true. Therefore, the Wald test of H0 based on any of
these estimators has asymptotically correct Type I error. These results hold under arbitrary misspecification
of the model (3).
We next compare the power of γˆ1 and ψˆstd, generalizing Theorem 3.1.
Theorem 5.2. Consider any function g satisfying the assumptions above. Let (γˆ0, γˆ1, γˆ2) denote the solution
to (4), and define the standardized estimator ψˆstd as (5). Consider any set of alternatives {P (ν) : ν > 0}
satisfying the assumptions in Section 3. The asymptotic relative efficiency for testing H0, comparing Wald
statistics based on ψˆstd versus γˆ1, is 1.
The theorem implies that the standardized estimator is asymptotically as efficient as γˆ1 for testing H0. This
holds under arbitrary misspecification of (3). Also, we prove a generalization of Corollary 1 to the setup of
this section in the Appendix.
Consider the special case where g(x) = x. Then (3) is the linear regression model E(Y |A,B) =
γ0 + γ1A + γ
′
2B. The GLM coefficient estimator γˆ1, defined as the solution to (4), is the ordinary least
squares estimator of γ1. Due to cancellation of terms in (5), the standardized estimator ψˆstd is identical
to γˆ1. This estimator is called the analysis of covariance (ANCOVA) estimator. Yang and Tsiatis (2001)
proved that this estimator is consistent for the average treatment effect E(Y |A = 1) − E(Y |A = 0) and
has equal or greater precision compared to the unadjusted estimator, asymptotically, under arbitrary model
misspecification. Theorem 5.2 holds trivially for the case of g(x) = x, since we have ψˆstd = γˆ1. This
11
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equality also holds for Poisson regression with canonical link function g(x) = log(x), if the standardized
estimator uses the log rate-ratio contrast function r(µ0, µ1) = log(µ1/µ0). To the best of our knowledge,
these are the only cases where γˆ1 and ψˆstd are identical.
6 Discussion
Asymptotically valid confidence intervals for the average treatment effect can be constructed by using the
nonparametric bootstrap applied to the standardized estimator. When baseline variables are moderately to
strongly prognostic for the outcome, these confidence intervals can have shorter average widths than those
constructed based on the unadjusted estimator, asymptotically.
The primary analysis in a confirmatory randomized trial needs to be prespecified in the study protocol.
When using an adjusted estimator, this requires specifying the list of baseline variables to be used and
the precise method (e.g., the standardized estimator using a logistic regression model with main terms for
treatment and baseline variables). A challenging practical problem is how to select baseline variables. The
number of variables should not be too large compared to the sample size of the trial, though it is an open
problem to determine what “too large” means. A conservative approach would be to pick a few key baseline
variables that are expected to be prognostic for the outcome based on clinical knowledge and prior data.
We focused on trials with simple randomization, but randomization stratified on key covariates can also
be used. In the latter case, the standardized estimator can adjust for the stratification variables and additional
baseline variables. Stratified randomization can typically only be applied to at most a few binary-valued
variables (since otherwise some stratum becomes too small to balance by design). This may leave other
prognostic variables that can be adjusted for to improve precision by using an adjusted estimator.
The standardized estimator can be modified to handle missing outcome data, as described, e.g., by Moore
and van der Laan (2009); Colantuoni and Rosenblum (2015). The estimator is consistent for the average
treatment effect under the following assumptions: the missing at random assumption, a correctly modeled
probability of censoring given baseline variables and study arm, and the assumption that this probability is
bounded away from 1.
The standardized estimator for binary outcomes has been applied in simulation studies by, e.g., Moore
and van der Laan (2009); Colantuoni and Rosenblum (2015); Steingrimsson et al. (2016), where substantial
efficiency gains were observed compared to the unadjusted estimator. Steingrimsson et al. (2016) provide
12
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R and Stata code that implement the standardized estimator and compute confidence intervals based on the
nonparametric bootstrap.
We focused on the standardized estimator (2) for its simplicity and ease of computation. Our results have
implications for the enhanced efficiency, standardized estimators of, e.g., Robins et al. (2007); Tan (2010);
Rotnitzky et al. (2012); Gruber and van der Laan (2012); Colantuoni and Rosenblum (2015), all of which
have equal or better efficiency compared to the standardized estimator (2) in our context of a randomized
trial (under suitable regularity conditions). Compared to (2), these estimators are more complex (and some
are more computationally challenging), but they have potential for greater efficiency gains when the logistic
regression model is misspecified. Colantuoni and Rosenblum (2015) describe these tradeoffs.
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Appendix
We start by proving Theorem 5.1, which is used to prove several of the other results.
Proof of Theorem 5.1. Assume the conditions in Section 5. Let γˆ denote the solution to the estimating
equations (4). For each a ∈ {0, 1}, define
ψˆ
(a)
std =
1
n
n∑
i=1
g−1(γˆ0 + γˆ1a+ γˆ′2Bi). (6)
We will prove that ψˆ(a)std converges in probability to E(Y |A = a), for each a ∈ {0, 1}. (Throughout this
proof, expectation E is with respect to P0.)
Since γˆ is the solution to the estimating equations (4), it follows from the regularity conditions (which
we assumed in Section 5) of Theorems 5.9 and 5.21 of van der Vaart (1998, pp. 46, 52) that γˆ converges in
probability to the solution γ¯ to E
{
Y − g−1(γ0 + γ1A+ γ′2B)
}
(1, A,B′)′ = 0. This implies
EY = Eg−1(γ¯0 + γ¯1A+ γ¯′2B) = (1/2)Eg
−1(γ¯0 + γ¯′2B) + (1/2)Eg
−1(γ¯0 + γ¯1 + γ¯′2B);
EAY = EAg−1(γ¯0 + γ¯1A+ γ¯′2B) = (1/2)Eg
−1(γ¯0 + γ¯1 + γ¯′2B),
which follow from A and B being independent. Since EY = EY A+ EY (1− A), it follows that for each
a ∈ {0, 1}, we have E(Y |A = a) = Eg−1(γ¯0 + γ¯1a + γ¯′2B). Since for each a ∈ {0, 1} the estimator
ψˆ
(a)
std converges in probability to Eg
−1(γ¯0 + γ¯1a + γ¯′2B), we have shown ψˆ
(a)
std converges in probability
to E(Y |A = a). This shows the standardized estimator ψˆstd = ψˆ(1)std − ψˆ(0)std converges in probability to
E(Y |A = a) − E(Y |A = 0). This also holds for ψˆunadj . Therefore, each of the estimators converges to 0
in probability if and only if H0 is true. It remains to show this for γˆ1.
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It follows from the above arguments that
E(Y |A = 1)− E(Y |A = 0) = E{g−1(γ¯0 + γ¯1 + γ¯′2B)} − E{g−1(γ¯0 + γ¯′2B)}. (7)
Since we assumed g−1(x) is strictly monotone, the right side of (7) equals 0 if and only if γ¯1 = 0. Therefore,
γˆ1 converges to 0 in probability if and only if H0 is true.
Proof of Theorem 5.2. The estimators below are as defined in Section 5. By Theorem 5.1, both the GLM
coefficient estimator and the standardized estimator converge to 0 in probability under any P (0) ∈ H0. We
use the following change of variables: A∗ = 2A− 1. Then (3) is equivalent to the following:
E(Y |A∗, B) = g−1(γ∗0 + γ∗1A∗ + γ∗
′
2 B), (8)
where γ∗0 = γ0 + γ1/2, γ∗1 = γ1/2, γ∗2 = γ2. Denote the corresponding estimated coefficients by adding
the hat symbol. The asymptotic relative efficiency is unchanged if we substitute A∗ for A and γˆ∗1 for γˆ1,
respectively, which we do below.
We assumed the regularity conditions in Lemma 7.6 of van der Vaart (1998, pp. 95), which include
the following: the set of distributions {P (ν) : ν ≥ 0} is dominated by a common measure λ, with corre-
sponding probability densities p(ν); the map ν 7→ {p(ν)}1/2 is continuously differentiable for every point
in the sample space, and all components of
∫ {(dp(ν)/dν)/p(ν)}2p(ν)dλ are well defined and the integral
is continuous in ν. Lemma 7.6 implies that {P (ν) : ν ≥ 0} is differentiable in quadratic mean with score
function l˙(ν)(B,A∗, Y ) = 1p(ν)>0(dp
(ν)/dν)/p(ν), where 1p(ν)>0 is the indicator variable taking value 1 if
p(ν) > 0 and 0 otherwise. Differentiability in quadratic mean at ν = 0 is assumed to be from the right,
i.e.,
∫ [{p(ν)}1/2 − {p(0)}1/2 − (1/2)νl˙(0){p(0)}1/2]2 dλ = o(ν2) as ν ↓ 0. We let l˙(B,A∗, Y ) with no
superscript denote l˙(0)(B,A∗, Y ).
Define γ¯∗(ν) to be the probability limit (as n→∞) underP (ν) of the estimator γˆ∗. Let IFGLM (B,A∗, Y )
and IFstd(B,A∗, Y ) denote the influence functions for the estimators γˆ∗1 and ψˆstd, respectively, under P (0).
It follows from Theorem 5.21 of van der Vaart (1998, p. 52) that
IFGLM (B,A
∗, Y ) =
1
E(0)h˙
{
γ¯∗0(0) + γ¯∗
′
2 (0)B
} [Y − g−1 {γ¯∗0(0) + γ¯∗′2 (0)B}]A∗, (9)
IFstd(B,A
∗, Y ) = 2
[
Y − g−1
{
γ¯∗0(0) + γ¯
∗′
2 (0)B
}]
A∗, (10)
where we used that γ¯∗1(0) = 0 under P (0), which follows from Theorem 5.1. Define avarGLM (ν) and
avarstd (ν) to be the variance of IFGLM (B,A∗, Y ) and IFstd(B,A∗, Y ), respectively, under P (ν). Direct
calculation gives that at ν = 0,
avarGLM (0) =
{
E(0)h˙
(
γ¯∗0 + γ¯
∗′
2 B
)}−2
E(0)
[{
Y − h(γ¯∗0 + γ¯∗
′
2 B)
}2]
, (11)
avarstd(0) = 4E(0)
[{
Y − h(γ¯∗0 + γ¯∗
′
2 B)
}2]
. (12)
By the above conditions and the assumption that P (ν) converges in total variation distance to P (0) as
ν ↓ 0, it follows that for any bounded, measurable function f(B,A∗, Y ), we have
E(0) l˙(B,A∗, Y )f(B,A∗, Y ) = − d
dν
E(ν)f(B,A∗, Y )
∣∣∣∣
ν=0+
, (13)
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where the + indicates the derivative is taken from the right. Also, since A∗ is independent of B for each
P (ν), the score l˙(B,A∗, Y ) is orthogonal (under E(0)) to any square-integrable function of A∗, B that has
mean zero given B. We then have
E(0) l˙(B,A∗, Y )IFstd(B,A∗, Y ) = 2E(0) l˙(B,A∗, Y )
[
Y − g−1
{
γ¯∗0(0) + γ¯
∗′
2 (0)B
}]
A∗
= 2E(0) l˙(B,A∗, Y )Y (14)
= − d
dν
(
2E(ν)Y A∗
)∣∣∣∣
ν=0+
(15)
= − d
dν
{µ1(ν)− µ0(ν)}
∣∣∣∣
ν=0+
< 0, (16)
where (14) follows from E(0)(A∗|B) = E(0)A∗ = 0 and that l˙(B,A∗, Y ) is orthogonal (under E(0)) to
any square-integrable function of A∗, B that has mean zero given B; (15) follows from (13); (16) follows
from the assumption that µ1(ν)−µ0(ν) is right differentiable with positive right-derivative. It follows from
analogous arguments as above, but applied to IFGLM instead of IFstd and using (9), that
E(0) l˙(B,A∗, Y )IFGLM (B,A∗, Y ) = − 1
2E(0)h˙
{
γ¯∗0(0) + γ¯∗
′
2 (0)B
} d
dν
{µ1(ν)− µ0(ν)}
∣∣∣∣
ν=0+
.(17)
We next apply Le Cam’s Third Lemma (van der Vaart, 1998, p. 90) to derive the asymptotic distributions
of the two estimators under local alternatives P (νn) for νn proportional to n−1/2, as n→∞. The conditions
of the lemma are met since our assumed regularity conditions imply local asymptotic normality (van der
Vaart, 1998, p. 94), and mutual contiguity of P (ν) and P (0) (as ν ↓ 0) holds by our assumption that P (ν)
converges to P (0) in total variation distance. Define
γ∗
1
(ν) = νE(0) l˙(B,A∗, Y )IFGLM (B,A∗, Y ), ψ(ν) = νE(0) l˙(B,A∗, Y )IFstd(B,A∗, Y ). (18)
Le Cam’s Third Lemma implies for any h ≥ 0, for νn = hn−1/2,
n1/2
{
γˆ∗1 − γ∗1(νn)
avarGLM (νn)
1/2
}
νn−→ N(0, 1), n1/2
{
ψˆstd − ψ (νn)
avarstd (νn)
1/2
}
νn−→ N(0, 1), (19)
where for each n > 0, the estimators γˆ1 and ψˆstd in the expressions above are based on n independent,
identically distributed draws from P (νn).
Define γ˙∗1 = dγ∗1/dν
∣∣∣
ν=0+
and ψ˙ = dψ/dν
∣∣
ν=0+
. It follows from Theorem 14.19 of van der Vaart
(1998, p. 201) that the asymptotic relative efficiency comparing the standardized and GLM coefficient
estimators equals the following square of the ratio of slopes of the corresponding statistics:{
γ˙∗1
ψ˙
}2{avarGLM (0)
avarstd(0)
}−1
. (20)
It follows from (16), (17), and (18) that γ˙∗1/ψ˙ =
[
2E(0)h˙
{
γ¯∗0(0) + γ¯∗
′
2 (0)B
}]−1
. It then follows from
(11), (12), and (20) that the asymptotic relative efficiency of the GLM estimator γˆ∗1 versus the standardized
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estimator is
[
1
2Eh˙
{
γ¯∗0(0) + γ¯∗
′
2 (0)B
}]2
 4E
[{
Y − h(γ¯∗0(0) + γ¯∗
′
2 (0)B)
}2]
{
Eh˙
(
γ¯∗0(0) + γ¯∗
′
2 (0)B
)}−2
E
[{
Y − h(γ¯∗0(0) + γ¯∗′2 (0)B)
}2]
 = 1,
where all expectations are with respect to P (0). This completes the proof of Theorem 5.2.
Theorems 2.1 and 3.1 follow from analogous arguments as Theorems 5.1 and 5.2, respectively, using
g(x) = logit(x). In this special case, γˆ converges to the maximizer of the expected log-likelihood given in
Section 2.3, and asymptotic normality of γˆ follows from strict concavity of the expected log-likelihood and
Theorem 5.23 of van der Vaart (1998, p. 53).
Proof of Corollary 3.2. We prove the generalization of Corollary 1 to the setup in Section 5. Consider
any function g satisfying the assumptions in that section. The asymptotic relative efficiency of the GLM
coefficient estimator compared to the unadjusted estimator equals the analog of (20) with ψˆstd replaced
throughout by ψˆunadj . The first term in curly braces is unchanged, since ψˆunadj and ψˆstd are consistent
estimators of the same quantity. The second term in curly braces involves replacing avarstd by avarunadj . If
the model (3) is correctly specified, we have avarstd(0) ≤ avarunadj(0). Therefore, the asymptotic relative
efficiency of the GLM coefficient estimatorˆ¯γ∗1 compared to the unadjusted estimator ψˆunadj is at least 1.
Combining this result with Theorem 5.2 implies the generalization of Corollary 1 to the setup in Section 5.
Proof of Theorem 3.3. Let ∇r(x, y) = [r˙1(x, y), r˙2(x, y)]′, where the first and second component denote
the partial derivative w.r.t. the first and second component of r(x, y), respectively. The condition that
r = 0 under H0 implies that r(x, x) = 0 for all x. Differentiating both sides with respect to x implies
r˙1(x, x) + r˙2(x, x) = 0, from which it follows that
∇r(x, x) = [r˙1(x, x),−r˙1(x, x)]′ = r˙1(x, x)[1,−1]′. (21)
When using the contrast r, the parameter estimated by the standardized estimator under P (ν) is denoted
ψstd,r(ν) = r(µ0(ν), µ1(ν)). By our assumption that P (0) ∈ H0, we have µ0(0) = µ1(0). It follows from
equation (21) and the chain rule that
dψstd,r
dν
∣∣∣∣
ν=0+
= ∇r(µ0(0), µ1(0))′ ∗ [∂µ0/∂ν, ∂µ1/∂ν]′|ν=0+
= r˙1(µ0(0), µ0(0))[∂µ0/∂ν − ∂µ1/∂ν]|ν=0+ . (22)
The delta method and (21) imply that the asymptotic variance of the standardized estimator using the contrast
function r at ν = 0 is avarstd,r(0) = avarstd(0)[r˙1(µ0(0), µ0(0))]2, where avarstd(0) is defined in equation
(12). Combining this with (22) shows that(
dψstd,r
dν
∣∣∣∣
ν=0+
)2
/avarstd,r(0) =
[(∂µ0/∂ν − ∂µ1/∂ν)|ν=0+ ]2
avarstd(0)
,
which is independent of the choice of r. This combined with equation (20) proves Theorem 3.3.
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